Global hepatitis B situation
- More than 257 million people are living with chronic hepatitis B (CHB) in the world.
- More than 887,000 people die every year due to complications of hepatitis B, including liver cirrhosis and liver cancer.
- Hepatitis B prevalence is highest in the Western Pacific Region and the African Region, where 6.2% and 6.1% of the adult population respectively are living with hepatitis B. In the Eastern Mediterranean Region, the South-East Asia Region and the European Region, an estimated 3.3%, 2.0% and 1.6%% of the general population respectively are living with hepatitis B. 0.7% of the population of the Region of the Americas is living with hepatitis B.
- The virus is transmitted through contact with the blood or other body fluids of a person living with hepatitis B, mother-to-child or person-to-person in early childhood.
- It can be prevented by a safe and effective vaccine.
Hepatitis B in Australia
- At the end of 2016, there were an estimated 230,034 people living with CHB in Australia.
- 63% of the estimated number of people living with CHB in Australia had been diagnosed.
- An estimated 412 deaths attributable to CHB occurred in 2016.
- People born in South-East Asia and North-East Asia, together with Aboriginal and Torres Strait Islander people, represented 3%, 4% and 3% of population in Australia, but accounted for half of all people living with CHB in Australia in 2016.
- In 2016, an estimated 7% of all people living with CHB were receiving treatment in Australia.
Hepatitis B in culturally and linguistically diverse communities in Australia
- The majority (61%) of people living with CHB in Australia in 2016 were born overseas, with the most common region of Asia–Pacific (41%). Smaller proportions were born in Europe (8%), Sub-Saharan Africa (4%), and North Africa and the Middle East (2%).
- Among those born overseas, a small number of countries comprise the majority of people affected by CHB, predominantly those in the Asia–Pacific region.
Hepatitis B in NSW
- An estimated 83,812 people in NSW were living with CHB in 2016, representing 1.08% of the population.
- There were 2391 new notifications of CHB in NSW.
- 9.6% of the total living with CHB in 2016 took up treatment with 65,106 not in care.